Literature DB >> 26552907

Robotic-Assisted Surgery Improves the Quality of Total Mesorectal Excision for Rectal Cancer Compared to Laparoscopy: Results of a Case-Controlled Analysis.

Pierre Allemann1, Céline Duvoisin1, Luca Di Mare1, Martin Hübner1, Nicolas Demartines1, Dieter Hahnloser2.   

Abstract

BACKGROUND: The use of a robotic surgical system is claimed to allow precise traction and counter-traction, especially in a narrow pelvis. Whether this translates to improvement of the quality of the resected specimen is not yet clear. The aim of the study was to compare the quality of the TME and the short-term oncological outcome between robotic and laparoscopic rectal cancer resections.
METHODS: 20 consecutive robotic TME performed in a single institution for rectal cancer (Rob group) were matched 1:2 to 40 laparoscopic resections (Lap group) for gender, body mass index (BMI), and distance from anal verge on rigid proctoscopy. The quality of TME was assessed by 2 blinded and independent pathologists and reported according to international standardized guidelines.
RESULTS: Both samples were well matched for gender, BMI (median 25.9 vs. 24.2 kg/m(2), p = 0.24), and level of the tumor (4.1 vs. 4.8 cm, p = 0.20). The quality of the TME was better in the Robotic group (complete TME: 95 vs. 55 %; p = 0.0003, nearly complete TME 5 vs. 37 %; p = 0.04, incomplete TME 0 vs. 8 %, p = 0.09). A trend for lower positive circumferential margin was observed in the Robotic group (10 vs. 25 %, p = 0.1).
CONCLUSIONS: These results suggest that robotic-assisted surgery improves the quality of TME for rectal cancer. Whether this translates to better oncological outcome needs to be further investigated.

Entities:  

Mesh:

Year:  2016        PMID: 26552907     DOI: 10.1007/s00268-015-3303-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Robotic versus laparoscopic intersphincteric resection for low rectal cancer: comparison of the operative, oncological, and functional outcomes.

Authors:  Byung-Eun Yoo; Jae-Sung Cho; Jae-Won Shin; Dong-Won Lee; Jung-Myun Kwak; Jin Kim; Seon-Hahn Kim
Journal:  Ann Surg Oncol       Date:  2014-10-18       Impact factor: 5.344

Review 2.  Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of eight studies.

Authors:  Binghong Xiong; Li Ma; Wei Huang; Qikang Zhao; Yong Cheng; Jingshan Liu
Journal:  J Gastrointest Surg       Date:  2014-11-14       Impact factor: 3.452

3.  Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer.

Authors:  Annibale D'Annibale; Graziano Pernazza; Igor Monsellato; Vito Pende; Giorgio Lucandri; Paolo Mazzocchi; Giovanni Alfano
Journal:  Surg Endosc       Date:  2013-01-05       Impact factor: 4.584

4.  Oncologic outcomes and perioperative clinicopathologic results after robot-assisted tumor-specific mesorectal excision for rectal cancer.

Authors:  Seung Hyuk Baik; Nam Kyu Kim; Dae Ro Lim; Hyuk Hur; Byung So Min; Kang Young Lee
Journal:  Ann Surg Oncol       Date:  2013-02-16       Impact factor: 5.344

5.  Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial.

Authors:  Sung-Bum Kang; Ji Won Park; Seung-Yong Jeong; Byung Ho Nam; Hyo Seong Choi; Duck-Woo Kim; Seok-Byung Lim; Taek-Gu Lee; Dae Yong Kim; Jae-Sung Kim; Hee Jin Chang; Hye-Seung Lee; Sun Young Kim; Kyung Hae Jung; Yong Sang Hong; Jee Hyun Kim; Dae Kyung Sohn; Dae-Hyun Kim; Jae Hwan Oh
Journal:  Lancet Oncol       Date:  2010-06-16       Impact factor: 41.316

6.  Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial.

Authors:  Pierre J Guillou; Philip Quirke; Helen Thorpe; Joanne Walker; David G Jayne; Adrian M H Smith; Richard M Heath; Julia M Brown
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

7.  What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy?

Authors:  Atthaphorn Trakarnsanga; Mithat Gonen; Jinru Shia; Karyn A Goodman; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Martin R Weiser
Journal:  Ann Surg Oncol       Date:  2013-01-18       Impact factor: 5.344

8.  Robotic versus laparoscopic low anterior resection of rectal cancer: short-term outcome of a prospective comparative study.

Authors:  Seung Hyuk Baik; Hye Youn Kwon; Jin Soo Kim; Hyuk Hur; Seung Kook Sohn; Chang Hwan Cho; Hoguen Kim
Journal:  Ann Surg Oncol       Date:  2009-03-17       Impact factor: 5.344

Review 9.  Does robotic rectal cancer surgery offer improved early postoperative outcomes?

Authors:  Rosaria Scarpinata; Emad H Aly
Journal:  Dis Colon Rectum       Date:  2013-02       Impact factor: 4.585

10.  Long-term oncologic outcomes of robotic low anterior resection for rectal cancer: a comparative study with laparoscopic surgery.

Authors:  Eun Jung Park; Min Soo Cho; Se Jin Baek; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Kang Young Lee; Nam Kyu Kim
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

View more
  25 in total

Review 1.  Robotics Total Mesorectal Excision Up To the Minute.

Authors:  Homoud Alawfi; Ho Seung Kim; Seung Yoon Yang; Nam Kyu Kim
Journal:  Indian J Surg Oncol       Date:  2020-06-04

Review 2.  A review on robotic surgery in rectal cancer.

Authors:  Zairul Azwan Mohd Azman; Seon-Hahn Kim
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

3.  Multiquadrant robotic colorectal surgery: the da Vinci Xi vs Si comparison.

Authors:  Bogdan Protyniak; Jeffrey Jorden; Russell Farmer
Journal:  J Robot Surg       Date:  2017-03-08

Review 4.  Robotic surgery for rectal cancer as a platform to build on: review of current evidence.

Authors:  Pietro Achilli; Fabian Grass; David W Larson
Journal:  Surg Today       Date:  2020-05-04       Impact factor: 2.549

5.  Robotic Versus Conventional Laparoscopic Surgery for Colorectal Cancer: A Systematic Review and Meta-Analysis with Trial Sequential Analysis.

Authors:  Ka Ting Ng; Azlan Kok Vui Tsia; Vanessa Yu Ling Chong
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

6.  Robotic-assisted total mesorectal excision (TME) for rectal cancer results in a significantly higher quality of TME specimen compared to the laparoscopic approach-report of a single-center experience.

Authors:  Heiko Aselmann; Jan-Niclas Kersebaum; Alexander Bernsmeier; Jan Henrik Beckmann; Thorben Möller; Jan Hendrik Egberts; Clemens Schafmayer; Christoph Röcken; Thomas Becker
Journal:  Int J Colorectal Dis       Date:  2018-07-04       Impact factor: 2.571

7.  Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database.

Authors:  Tarik Sammour; Songphol Malakorn; Brian K Bednarski; Harmeet Kaur; Ui Sup Shin; Craig Messick; Yi-Qian Nancy You; George J Chang
Journal:  Ann Surg       Date:  2018-03       Impact factor: 12.969

8.  Completeness of total mesorectum excision of laparoscopic versus robotic surgery: a review with a meta-analysis.

Authors:  Marco Milone; Michele Manigrasso; Nunzio Velotti; Stefania Torino; Antonietta Vozza; Giovanni Sarnelli; Giovanni Aprea; Francesco Maione; Nicola Gennarelli; Mario Musella; Giovanni Domenico De Palma
Journal:  Int J Colorectal Dis       Date:  2019-05-06       Impact factor: 2.571

9.  Does robotic rectal cancer surgery improve the results of experienced laparoscopic surgeons? An observational single institution study comparing 168 robotic assisted with 184 laparoscopic rectal resections.

Authors:  Rogier M P H Crolla; Paul G Mulder; George P van der Schelling
Journal:  Surg Endosc       Date:  2018-05-14       Impact factor: 4.584

Review 10.  [Robot-assisted rectal surgery: hype or progress?].

Authors:  T Becker; J E Egberts; C Schafmayer; H Aselmann
Journal:  Chirurg       Date:  2016-07       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.